{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Health Affairs This Week","title":"The Cost of Insulin","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/a3aa9cdc\"></iframe>","width":"100%","height":180,"duration":696,"description":"Health Affairs' Jessica Bylander and Chris Fleming dive into the complex world of insulin pricing and recent efforts to control its costs for the millions of Americans with diabetes.\nRead the Ahead of Print article on Medicare Advantage benchmarks by Michael Chernew and colleagues.\nRelated Links:\nSanofi announces insulin price cap after actions by Eli Lilly and Novo Nordisk (NBC News)\nWhy is insulin so expensive and difficult to cap? (AP News)\nCalifornia Picks Generic Drug Company Civica to Produce Low-Cost Insulin (Kaiser Health News)\nInsulin as Preventive Care: Why Not Eliminate Patient Cost Sharing? (Health Affairs Forefront)\nCurrently, more than 70 percent of our content is freely available — and we’d like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.","thumbnail_url":"https://img.transistorcdn.com/1yTEmrg3NcfwPvygDcOosqdCKJnotdzHk5P0Oq8y-us/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzE2NjA3LzE2MDY4/MzkyNjUtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}